Skip to main content

Der historische Hintergrund der Lithiumtherapie and -prophylaxe

  • Chapter
Die Lithiumtherapie
  • 56 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R, Moller HJ (1995) Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Aff Disord 33: 67–75

    Article  CAS  Google Scholar 

  • Angst J, Weis P, Grof P, Baastrup PC, Schou M (1970) Lithiumprophylaxis in recurrent affective disorders. Brit J Psychiatry 11: 604–614

    Article  Google Scholar 

  • Baastrup PC (1964) The use of lithium in manic-depressive psychosis. Comp Psychiatry 5: 396–408

    Article  Google Scholar 

  • Baastrup PC, Schou M (1967) Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 16:162-172 Baastrup PC, Schou M (1968) Prophylactic lithium. Lancet i: 1419–1422

    Google Scholar 

  • Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent depressive disorders. Lancet 2: 326–330

    Article  PubMed  CAS  Google Scholar 

  • Blackwell B, Shepherd M (1968) Prophylactic lithium: another therapeutic myth? An examination of the evidence to date. Lancet i: 968–971

    Google Scholar 

  • Cade JFJ (1949) Lithium salts in the treatment of psychotic-excitement. Med J Aust 36: 349–352

    Google Scholar 

  • Coppen A, Noguera R, Bailey J, Burns BH, Swami MS, Hare EH, Gardner R, Maggs R (1971) Prophylactic lithium in affective disorders: controlled trial. Lancet 2: 275–279

    Article  PubMed  CAS  Google Scholar 

  • Coppen A, Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C (1991) Does lithium reduce the mortality of recurrent mood disorders? J Aff Disord 23: 1–7

    Article  CAS  Google Scholar 

  • Felber W, Kyber A (1994) Suizide and Parasuizide während and aul3erhalb einer Lithium-Prophylaxe. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg.) Ziele and Ergebnisse der medikamentosen Prophylaxe affektiver Psychosen. Thieme, Stuttgart, S. 53–59

    Google Scholar 

  • Gitlin MJ (1993) Lithium-induced renal insufficiency. J Clin Psychopharmacol 13:276M–279

    Google Scholar 

  • Greil W, Ludwig-Mayerhofer W, Steller B, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1993) The recruitment process for a multicenter study on the longterm prophylactic treatment of afMüllerfective disorders. J Aff Disord 28: 257–265

    Article  CAS  Google Scholar 

  • Greil W, Ludwig-Mayerhofer W, Steller B, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1994) Lithiumoder Carbamazepinprophylaxe bei affektiven Psychosen? Ergebnisse einer kontrollierten, multizentrischen Studie. In: Müller-Oerlinghausen B, Berghofer A (Hrsg.) Ziele and Ergebnisse der medikamentosen Prophylaxe affektiver Psychosen. Thieme, Stuttgart, S. 113–119

    Google Scholar 

  • Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oer-linghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1996) Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomized study. J Aff Disord 40: 179–190

    Article  CAS  Google Scholar 

  • Hammond WA (1871) A Treatise on Diseases of the Nervous System. Appleton & Co., New York, p. 381

    Google Scholar 

  • Hartigan GP (1963) The use of lithium salts in affective disorders. Brit J Psychiatry 109: 810–814

    Article  CAS  Google Scholar 

  • Kallner G, Petterson U, (1995) Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiatr Scand 91: 48–51

    Article  PubMed  CAS  Google Scholar 

  • Knorring von L, Wahlin A, Nystrom K, Bohman SO (1990) Uraemia induced by longterm lithium treatment. Lithium 1: 251–253

    Google Scholar 

  • Lange C (1886) Om periodiske Depressionstilstande og deres Patogenese. Lunds Forlag, Copenhagen

    Google Scholar 

  • Lange F (1894) De vigtigste Sindssygdomegrupper i kort Omrids. Gyldendal, Copenhagen

    Google Scholar 

  • Lange C (1896) Periodische Depressionszustande and ihre Pathogenese auf dem Boden der harnsauren Diathese. Leopold Voss, Hamburg Leipzig

    Google Scholar 

  • Lange C (1897) Bidrag til Urinsyrediatesens Klinik. Hospitalstidende 5: 1–83

    Google Scholar 

  • Lenz G, Ahrens B, Denk E, Müller-Oerlinghausen B, Schratzberger-Topitz A, Simhandl C, Wancata J (1994) Mortalitat nach Ausscheiden aus der Lithiumambulanz. In: Müller-Oerlinghausen B, Berghofer A (Hrsg.) Ziele and Ergebnisse der medikamentosen Prophylaxe affektiver Psychosen. Thieme, Stuttgart, S. 49–52

    Google Scholar 

  • Müller-Oerlinghausen B, Ahrens B, Volk J, Grof P, Grof E, Schou M, Vestergaard P, Lenz G, Simhandl C, Thau K, Wolf R (1991) Reduced mortality of manic-depressive patients in long-term lithium treatment: and international collaborative study by IGSLi. Psychiat Res 36: 329–331

    Article  Google Scholar 

  • Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, Simhandl C, Thau K, Volk J, Wolf R, Wolf T (1992a) The effect of long-term lithium treatment on the mortality of patients with manic-depressive or schizo-affective illness. Acta Psychiatr Scand 86: 218–222

    Article  Google Scholar 

  • Müller-Oerlinghausen B, Miiser-Causemann B, Volk J (1992b) Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Aff Disord 25: 261–270

    Article  Google Scholar 

  • Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R (1994) Mortality during initial and during later lithium treatment: a collaborative study by the International Group for the Study of Lithiumtreated Patients (IGSLi). Acta Psychiatr Scand 90: 295–297

    Article  PubMed  Google Scholar 

  • A (1995) Mortality in recurrent mood disorders during periods on and off lithium: a complete population study in 362

    Google Scholar 

  • patients. Pharmacopsychiatry 28:8–13

    Google Scholar 

  • Schou M (1956) Lithiumterapi ved mani. Nord Med 55: 790–794

    PubMed  CAS  Google Scholar 

  • Schou M (1963) Normothymotics, „mood-normalizers”: are lithium and the imipramine drugs specific for affective disorders? Brit J Psychiatry 109: 803–809

    Article  CAS  Google Scholar 

  • Schou M (1973) Prophylactic lithium maintenance treatment in recurrent endogenous affective disorders. In: Gershon S, Shopsin B (eds) Lithium. Its role in psychiatric research and treatment. Plenum, New York, London, 269–294

    Google Scholar 

  • Schou M (1988) Effects of long-term lithium treatment on kidney function: an overview. Psychiatr Res 22: 287–296

    Article  CAS  Google Scholar 

  • Schou M (1993a) Personal observation

    Google Scholar 

  • Schou M (1993b) Lithium prophylaxis: about ‘naturalistic’ or clinical ‘practice’ studies. Lithium 4: 77–81

    Google Scholar 

  • Schou M (1993b) Lithium prophylaxis: about ‘naturalistic’ or clinical ‘practice’ studies. Lithium 4:77–81

    Google Scholar 

  • Schou M, Juel-Nielsen N, Stromgren E, Voldby H (1954) The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 17: 250–260

    Article  PubMed  CAS  Google Scholar 

  • Thies-Flechtner K, Seibert W, Walther A, Greil W, Müller-Oerlinghausen B (1994) Suizide bei rezidivprophylaktisch behandelten Patienten mit affektiven Psychosen. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg.) Ziele and Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme, Stuttgart, S. 61–64

    Google Scholar 

  • Waller DG, Edwards JG (1989) Lithium and the kidney: an update. Psychol Med 19: 825–831

    Article  PubMed  CAS  Google Scholar 

  • Wing AJ, Brunner FP, Geerlings W, Broyer M, Brynger H, Fassbinder W, Rissoni G, Selwood NH, Tufeson G (1989) Contribution of toxic nephropathies to end-stage renal failure in Europe: a report from the EDTA-ERA registry. Toxicol Lett 46:281M–292

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schou, M. (1997). Der historische Hintergrund der Lithiumtherapie and -prophylaxe. In: Müller-Oerlinghausen, B., Berghöfer, A., Greil, W. (eds) Die Lithiumtherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60819-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60819-3_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64570-9

  • Online ISBN: 978-3-642-60819-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics